# Ticagrelol Versus Aspirin in Ischemic Stroke

Study · id `cardio:ct-nct03884530` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03884530](<https://clinicaltrials.gov/study/NCT03884530>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03884530

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 169 participants.

## Technical summary

Registry record NCT03884530. Randomized; no masking; primary purpose treatment. Start 2019-05-01 (actual); primary completion 2020-09-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 169 participants (enrolled count; ClinicalTrials.gov record NCT03884530, source copy `cardio:ctgov-nct03884530-2021-09-02`, retrieved 2026-10-26)
- Started: 2019-05-01 (actual) (ClinicalTrials.gov record NCT03884530, source copy `cardio:ctgov-nct03884530-2021-09-02`, retrieved 2026-10-26)
- Primary completion: 2020-09-30 (actual) (ClinicalTrials.gov record NCT03884530, source copy `cardio:ctgov-nct03884530-2021-09-02`, retrieved 2026-10-26)
- Completion: 2020-09-30 (actual) (ClinicalTrials.gov record NCT03884530, source copy `cardio:ctgov-nct03884530-2021-09-02`, retrieved 2026-10-26)
- Countries: Egypt (ClinicalTrials.gov record NCT03884530, source copy `cardio:ctgov-nct03884530-2021-09-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03884530-2021-09-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Ticagrelol Versus Aspirin in Ischemic Stroke
- Condition: Acute Stroke
- Condition: Ischemic Stroke
- Intervention (Drug): Ticagrelor (Brilique) 90
- Intervention (Drug): Aspirin 75mg
- Lead sponsor: Kafrelsheikh University
- Lead sponsor class: OTHER
- Collaborator: Ain Shams University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Kafrelsheikh University (`cardio:org-kafrelsheikh-university`)
- Registry lists this organization as a collaborator: Ain Shams University (`cardio:org-ain-shams-university`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: A pilot study of the ticagrelor role in ischemic stroke secondary prevention (`cardio:pubmed-34515113`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: A randomized pilot study of the efficacy and safety of loading ticagrelor in acute ischemic stroke (`cardio:pubmed-36446950`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: a97ece40f55d105120f3c977e957ac520eae0931def28a1a838b7156683d47df
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
